Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 2Leukemia 2Esophageal Neoplasms 2Adenocarcinoma Of Esophagus 2Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Prolactinoma 1Pituitary Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Plasma Cell 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Large Granular Lymphocytic 1Immunoglobulin Light-chain Amyloidosis 1Immunoblastic Lymphadenopathy 1Growth Hormone-Secreting Pituitary Adenoma 1Gliosarcoma 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Chondrosarcoma 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 20fludarabine phosphate 16Peripheral Blood Stem Cell Transplantation 11Tacrolimus 10Mycophenolic Acid 10Whole-Body Irradiation 9Cyclosporine 8Methotrexate 7Etoposide 7Busulfan 7Antilymphocyte Serum 7Vincristine 6Prednisone 6Melphalan 6Doxorubicin 5Rituximab 4Transplantation 3Sirolimus 3Radiotherapy 3Methylprednisolone 3Gemcitabine 3Brentuximab Vedotin 3Alemtuzumab 3nelarabine 2merphos 2etoposide phosphate 2Therapeutics 2Prednisolone 2Panobinostat 2Lenalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Immunoblastic Lymphadenopathy × Microarray Analysis × Clear all
NCT01336933 2023-09-22

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

University of Nebraska

Phase 2 Completed
34 enrolled 12 charts
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡